Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

CUPR vs UEEC: stock comparison and AI forecast

Cuprina Holdings (Cayman) Ltd (CUPR) and United Health Products, Inc. (UEEC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies

CUPR Cuprina Holdings (Cayman) Ltd

Market Cap
$12M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
OTC · Orthopedic, Prosthetic & Surgical Appliances & Supplies

UEEC United Health Products, Inc.

Market Cap
$10M
P/E Ratio
3.8x
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

CUPR · UEEC

Key facts

  • CUPR is 1.2 times larger than UEEC by market capitalization ($12M against $10M).
  • Both companies share the SEC industry classification Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCUPRUEEC
Market Cap$12M$10M
P/E Ratio–3.80x
EPS–$0.01

Profitability & Margins

MetricCUPRUEEC
ROIC–23.7%
Tax Rate–0.0%

Financial Health

MetricCUPRUEEC
Current Ratio–0.02x
Interest Coverage–-3.3x
Working Capital–-$4M

Cash Flow

MetricCUPRUEEC
Operating Cash Flow–-$670K

Income Statement

MetricCUPRUEEC
Operating Income–-$930K
R&D Expense–$120K
SG&A Expense–$810K

Dividend & Shareholder Information

MetricCUPRUEEC
Shares Outstanding7M263M
FAQ

CUPR vs UEEC: stock comparison and AI forecast

Which is bigger, CUPR or UEEC?

CUPR is 1.2 times larger than UEEC by market capitalization ($12M against $10M).

Which one does Intratio's AI model rank higher, CUPR or UEEC?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.